| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/06/2023 | Acumen Pharmaceuticals, Inc. | | Grant | Stock Option (right to buy) | 25k | $5.20 | $130k | | 06/06/2023 |
| 05/25/2023 | Passage BIO, Inc. | PASG | Grant | Director Stock Option (Right to Buy) | 24k | $1.00 | $24k | | 05/25/2023 |
| 01/04/2023 | Acumen Pharmaceuticals, Inc. | | Grant | Stock Option Grant (right to buy) | 50k | $5.46 | $273k | | 01/04/2023 |
| 05/26/2022 | Passage BIO, Inc. | PASG | Grant | Director Stock Option (Right to Buy) | 24k | $1.76 | $42.2k | | 05/26/2022 |
| 05/27/2021 | Passage BIO, Inc. | PASG | Grant | Director Stock Option (Right to Buy) | 33.8k | $13.83 | $468k | | 05/27/2021 |
| 03/26/2019 | Atara Biotherapeutics, Inc. | ATRA | Grant | Common Stock | 10k | $0.00 | $0 | | 03/26/2019 |
| 02/15/2019 | Atara Biotherapeutics, Inc. | ATRA | Exercise | Employee Stock Option (Right to Buy) | 4k | $14.30 | $57.2k | | 02/15/2019 |
| 02/15/2019 | Atara Biotherapeutics, Inc. | ATRA | Sale | Common Stock | 5.9k | $40.00 | $236.4k | | 02/15/2019 |
| 02/06/2019 | Atara Biotherapeutics, Inc. | ATRA | Grant | Common Stock | 12.3k | $0.00 | $0 | | 02/06/2019 |
| 02/06/2019 | Atara Biotherapeutics, Inc. | ATRA | Payment of Exercise | Common Stock | 1.2k | $38.47 | $46.8k | | 02/06/2019 |
| 02/06/2019 | Atara Biotherapeutics, Inc. | ATRA | Grant | Employee Stock Option (Right to Buy) | 24.6k | $38.47 | $947.3k | | 02/06/2019 |
| 05/15/2018 | Atara Biotherapeutics, Inc. | ATRA | Exercise | Employee Stock Option (Right to Buy) | 16.3k | $14.30 | $233.6k | | 05/15/2018 |
| 05/15/2018 | Atara Biotherapeutics, Inc. | ATRA | Sale | Common Stock | 16.3k | $45.02 | $735.4k | | 05/15/2018 |
| 05/08/2018 | Atara Biotherapeutics, Inc. | ATRA | Sale | Common Stock | 1.5k | $40.15 | $62k | | 05/08/2018 |
| 02/06/2018 | Atara Biotherapeutics, Inc. | ATRA | Grant | Common Stock | 12.5k | $0.00 | $0 | | 02/06/2018 |
| 02/06/2018 | Atara Biotherapeutics, Inc. | ATRA | Grant | Employee Stock Option (Right to Buy) | 25k | $35.80 | $895k | | 02/06/2018 |